keyword
https://read.qxmd.com/read/37300660/fusion-sequencing-via-terminator-assisted-synthesis-ftas-seq-identifies-tmprss2-fusion-partners-in-prostate-cancer
#21
JOURNAL ARTICLE
Ugnė Drazdauskienė, Žana Kapustina, Justina Medžiūnė, Varvara Dubovskaja, Rasa Sabaliauskaitė, Sonata Jarmalaitė, Arvydas Lubys
Genetic rearrangements that fuse an androgen-regulated promoter area with a protein-coding portion of an originally androgen-unaffected gene are frequent in prostate cancer, with the fusion between transmembrane serine protease 2 (TMPRSS2) and ETS transcription factor ERG (ERG) (TMPRSS2-ERG fusion) being the most prevalent. Conventional hybridization- or amplification-based methods can test for the presence of expected gene fusions, but the exploratory analysis of currently unknown fusion partners is often cost-prohibitive...
June 2023: Molecular Oncology
https://read.qxmd.com/read/37236546/molecular-and-cytogenetic-features-of-ntrk-fusions-enriched-in-braf-and-ret-double-negative-papillary-thyroid-cancer
#22
JOURNAL ARTICLE
Shafei Wu, Yuanyuan Liu, Kaimi Li, Zhiyong Liang, Xuan Zeng
Rare NTRK-driven malignant neoplasms can be effectively inhibited by anti-TRK agents. The discovery of NTRK1/2/3-rich tumours in papillary thyroid cancer (PTC) patients is a precondition for the rapid identification of NTRK fusion tumours. Knowledge of NTRK gene activation is critical to accurately detect NTRK status. A total of 229 BRAF V600E-negative samples from PTC patients were analysed in this study. Break-apart fluorescence in situ hybridisation (FISH) was performed to detect RET fusion. NTRK status was analysed using FISH, DNA- and RNA-based next-generation sequencing (NGS), and quantitative reverse transcription-polymerase chain reaction (RT-qPCR)...
May 24, 2023: Journal of Molecular Diagnostics: JMD
https://read.qxmd.com/read/37193944/bifunctional-protein-arsr-m-contributes-to-arsenite-methylation-and-resistance-in-brevundimonas-sp-m20
#23
JOURNAL ARTICLE
Congcong Li, Gongli Zong, Xi Chen, Meixia Tan, Wenhui Gao, Jiafang Fu, Peipei Zhang, Bing Wang, Guangxiang Cao
BACKGROUND: Arsenic (As) with various chemical forms, including inorganic arsenic and organic arsenic, is the most prevalent water and environmental toxin. This metalloid occurs worldwide and many of its forms, especially arsenite [As(III)], cause various diseases including cancer. Organification of arsenite is an effective way for organisms to cope with arsenic toxicity. Microbial communities are vital contributors to the global arsenic biocycle and represent a promising way to reduce arsenite toxicity...
May 17, 2023: BMC Microbiology
https://read.qxmd.com/read/37107676/detection-of-a-novel-msi2-c17orf64-transcript-in-a-patient-with-aggressive-adenocarcinoma-of-the-gastroesophageal-junction-a-case-report
#24
Anna Ferrari, Roberto Fiocca, Elena Bonora, Chiara Domizio, Eugenio Fonzi, Davide Angeli, Gian Domenico Raulli, Sandro Mattioli, Giovanni Martinelli, Chiara Molinari
Adenocarcinoma of the esophagus (EAC) and gastroesophageal junction (GEJ-AC) is associated with poor prognosis, treatment resistance and limited systemic therapeutic options. To deeply understand the genomic landscape of this cancer type, and potentially identify a therapeutic target in a neoadjuvant chemotherapy non-responder 48-year-old man, we adopted a multi-omic approach. We simultaneously evaluated gene rearrangements, mutations, copy number status, microsatellite instability and tumor mutation burden...
April 15, 2023: Genes
https://read.qxmd.com/read/36801905/generating-in-vitro-models-of-ntrk-fusion-mesenchymal-neoplasia-as-tools-for-investigating-kinase-oncogenic-activation-and-response-to-targeted-therapy
#25
JOURNAL ARTICLE
Fabio Vanoli, Laurie Herviou, Yusuke Tsuda, Patricia Sung, Ziyu Xie, Eve Fishinevich, Soe S Min, William Mallen, Henry de Traux de Wardin, Yanming Zhang, Maria Jasin, Cristina R Antonescu
The discovery of neurotrophic tyrosine receptor kinase (NTRK) gene fusions as pan-tumor oncogenic drivers has led to new personalized therapies in oncology. Recent studies investigating NTRK fusions among mesenchymal neoplasms have identified several emerging soft tissue tumor entities displaying various phenotypes and clinical behaviors. Among them, tumors resembling lipofibromatosis or malignant peripheral nerve sheath tumors often harbor intra-chromosomal NTRK1 rearrangements, while most infantile fibrosarcomas are characterized by canonical ETV6::NTRK3 fusions...
February 17, 2023: Oncogenesis
https://read.qxmd.com/read/36778239/discovery-of-a-polymorphic-gene-fusion-via-bottom-up-chimeric-rna-prediction
#26
Justin Elfman, Lynette Goins, Tessa Heller, Sandeep Singh, Yuh-Hwa Wang, Hui Li
UNLABELLED: Gene fusions and their chimeric products are typically considered hallmarks of cancer. However, recent studies have found chimeric transcripts in non-cancer tissues and cell lines. In addition, efforts to annotate structural variation at large scale have found examples of gene fusions with potential to produce chimeric transcripts in normal tissues. In this report, we provide a means for targeting population-specific chimeric RNAs to enrich for those generated by gene fusion events...
February 3, 2023: bioRxiv
https://read.qxmd.com/read/36776529/oncogenic-inspiration-for-programmable-activators
#27
David Ichikawa, Marcus Noyes
The discovery of regulatory domains has been limited to the investigation of transcription factors and homologous protein sequences. In this issue of Cell Genomics , motivated by an oncogenic protein fusion, Tak et al.1 direct the regulatory potential of a nontraditional effector domain to novel genomic loci with fusions to programmable DNA-binding domains.
April 13, 2022: Cell Genom
https://read.qxmd.com/read/36754959/morf-and-moz-acetyltransferases-target-unmethylated-cpg-islands-through-the-winged-helix-domain
#28
JOURNAL ARTICLE
Dustin C Becht, Brianna J Klein, Akinori Kanai, Suk Min Jang, Khan L Cox, Bing-Rui Zhou, Sabrina K Phanor, Yi Zhang, Ruo-Wen Chen, Christopher C Ebmeier, Catherine Lachance, Maxime Galloy, Amelie Fradet-Turcotte, Martha L Bulyk, Yawen Bai, Michael G Poirier, Jacques Côté, Akihiko Yokoyama, Tatiana G Kutateladze
Human acetyltransferases MOZ and MORF are implicated in chromosomal translocations associated with aggressive leukemias. Oncogenic translocations involve the far amino terminus of MOZ/MORF, the function of which remains unclear. Here, we identified and characterized two structured winged helix (WH) domains, WH1 and WH2, in MORF and MOZ. WHs bind DNA in a cooperative manner, with WH1 specifically recognizing unmethylated CpG sequences. Structural and genomic analyses show that the DNA binding function of WHs targets MORF/MOZ to gene promoters, stimulating transcription and H3K23 acetylation, and WH1 recruits oncogenic fusions to HOXA genes that trigger leukemogenesis...
February 8, 2023: Nature Communications
https://read.qxmd.com/read/36715552/extrachromosomal-dna-amplification-contributes-to-small-cell-lung-cancer-heterogeneity-and-is-associated-with-worse-outcomes
#29
JOURNAL ARTICLE
Lőrinc Sándor Pongor, Christopher W Schultz, Lorenzo Rinaldi, Darawalee Wangsa, Christophe E Redon, Nobuyuki Takahashi, Gavriel Fialkoff, Parth Desai, Yang Zhang, Sandra Burkett, Nadav Hermoni, Noa Vilk, Jenia Gutin, Rona Gergely, Yongmei Zhao, Samantha Nichols, Rasa Vilimas, Linda Sciuto, Chante Graham, Juan Manuel Caravaca, Sevilay Turan, Shen Tsai-Wei, Vinodh N Rajapakse, Rajesh Kumar, Deep Upadhyay, Suresh Kumar, Yoo Sun Kim, Nitin Roper, Bao Tran, Stephen M Hewitt, David E Kleiner, Mirit I Aladjem, Nir Friedman, Gordon L Hager, Yves Pommier, Thomas Ried, Anish Thomas
UNLABELLED: Small-cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer. Oncogenic MYC amplifications drive SCLC heterogeneity, but the genetic mechanisms of MYC amplification and phenotypic plasticity, characterized by neuroendocrine and nonneuroendocrine cell states, are not known. Here, we integrate whole-genome sequencing, long-range optical mapping, single-cell DNA sequencing, and fluorescence in situ hybridization to find extrachromosomal DNA (ecDNA) as a primary source of SCLC oncogene amplifications and driver fusions...
April 3, 2023: Cancer Discovery
https://read.qxmd.com/read/36622760/nifuroxazide-activates-the-parthanatos-to-overcome-tmprss2%C3%AF-erg-fusion-positive-prostate-cancer
#30
JOURNAL ARTICLE
Chengxun Li, Jiale Zhang, Qiming Wu, Anuj Kumar, Guihong Pan, David J Kelvin
Fusion of the ETS (E-26 transformation-specific)-related gene (ERG) with transmembrane serine protease 2 (TMPRSS2) is a crucial step in the occurrence and progression of approximately 50% of prostate cancers. Despite significant progress in drug discovery, ERG inhibitors have yet to be approved for the clinical treatment of prostate cancer. In this study, we used computer-aided drug design (CADD)-based virtual screening to screen for potential inhibitors of ERG. In vivo and in vitro methods revealed that nifuroxazide inhibited the proliferation of a TMPRSS2:ERG fusion-positive prostate cancer cell line (VCaP) with an IC50 lower than that of ERG-negative prostate cancer cell lines (LNCaP, DU145 and WPMY cells)...
January 9, 2023: Molecular Cancer Therapeutics
https://read.qxmd.com/read/36585787/discovery-of-fusion-circular-rnas-in-leukemia-with-kmt2a-aff1-rearrangements-by-the-new-software-circfusion
#31
JOURNAL ARTICLE
Anna Dal Molin, Caterina Tretti Parenzan, Enrico Gaffo, Cristina Borin, Elena Boldrin, Lueder H Meyer, Geertruij Te Kronnie, Silvia Bresolin, Stefania Bortoluzzi
Chromosomal translocations in cancer genomes, key players in many types of cancers, generate chimeric proteins that drive oncogenesis. Genomes with chromosomal rearrangements can also produce fusion circular RNAs (f-circRNAs) by backsplicing of chimeric transcripts, as first shown in leukemias with PML::RARα and KMT2A::MLLT3 translocations and later in solid cancers. F-circRNAs contribute to the oncogenic processes and reinforce the oncogenic activity of chimeric proteins. In leukemia with KMT2A::AFF1 (MLL::AF4) fusions, we previously reported specific alterations of circRNA expression, but nothing was known about f-circRNAs...
December 30, 2022: Briefings in Bioinformatics
https://read.qxmd.com/read/36533189/slit2-signaling-stimulates-ewing-sarcoma-growth
#32
JOURNAL ARTICLE
Kruthi Suvarna, Panneerselvam Jayabal, Xiuye Ma, Yuzuru Shiio
Ewing sarcoma is a cancer of bone and soft tissue in children driven by EWS::ETS fusion, most commonly EWS::FLI1. Because current cytotoxic chemotherapies are not improving the survival of those with metastatic or recurrent Ewing sarcoma cases, there is a need for novel and more effective targeted therapies. While EWS::FLI1 is the major driver of Ewing sarcoma, EWS::FLI1 has been difficult to target. A promising alternative approach is to identify and target the molecular vulnerabilities created by EWS::FLI1...
2022: Genes & Cancer
https://read.qxmd.com/read/36527429/recent-advances-in-cancer-fusion-transcript-detection
#33
JOURNAL ARTICLE
Ryley Dorney, Bijay P Dhungel, John E J Rasko, Lionel Hebbard, Ulf Schmitz
Extensive investigation of gene fusions in cancer has led to the discovery of novel biomarkers and therapeutic targets. To date, most studies have neglected chromosomal rearrangement-independent fusion transcripts and complex fusion structures such as double or triple-hop fusions, and fusion-circRNAs. In this review, we untangle fusion-related terminology and propose a classification system involving both gene and transcript fusions. We highlight the importance of RNA-level fusions and how long-read sequencing approaches can improve detection and characterization...
December 17, 2022: Briefings in Bioinformatics
https://read.qxmd.com/read/36435508/transcriptome-diversity-assessment-of-gossypium-arboreum-fdh228-leaves-under-control-drought-and-whitefly-infestation-using-pacbio-long-reads
#34
JOURNAL ARTICLE
Muhammad Farooq, Rubab Zahra Naqvi, Imran Amin, Atiq Ur Rehman, Muhammad Asif, Shahid Mansoor
Alternative splicing (AS) and alternative polyadenylation (APA) are common mechanisms in eukaryotes to increase the complexity of transcriptomes and subsequently proteomes. Analysis of long reads transcriptomics data can result in the discovery of novel transcripts, splice sites, AS or APA events. Gossypium arboreum is an important cultivated cotton species and a putative contributor of the A sub-genome to the modern tetraploid cotton; and inherently tolerant to several biotic and abiotic stresses. Specifically, its variety 'FDH228' is considered to be an important resistance source...
November 23, 2022: Gene
https://read.qxmd.com/read/36387218/case-report-a-novel-reciprocal-ros1-cd74-fusion-in-a-nsclc-patient-partially-benefited-from-sequential-tyrosine-kinase-inhibitors-treatment
#35
Xugang Zhang, Baoming Wang, Chunyang Wang, Chengde Liao, Shiping Wang, Ran Cao, Tonghui Ma, Kun Wang
Background: The clinical significance of majority oncogenic novel fusions is still unknown due to scarcity. Reciprocal ROS1 translocation is a rare form of ROS1 fusion and has not yet been clearly analyzed. Case presentation: A 44-year-old Chinese woman with a large dimension in the left lobe of the lung was admitted to the hospital with IVB lung adenocarcinoma. It was discovered that intron 28 of ROS1 and intron 6 of CD74 produced a unique reciprocal ROS1 rearrangement...
2022: Frontiers in Oncology
https://read.qxmd.com/read/36358827/cic-rearranged-sarcomas-an-intriguing-entity-that-may-lead-the-way-to-the-comprehension-of-more-common-cancers
#36
REVIEW
Caterina Mancarella, Marianna Carrabotta, Lisa Toracchio, Katia Scotlandi
Capicua transcriptional repressor (CIC)-rearranged sarcoma, belonging to the undifferentiated round cells sarcoma family, is characterized by high metastatic rate and poor chemo response. CIC sarcoma represents a new entity harboring the recurrent chromosomal translocation between CIC and, in most of the cases, DUX4 . CIC-DUX4 imposes a CIC-specific transcriptional signature, which drives cell transformation, proliferation, and migration. While the discovery of the fusion represented the first evidence of a role of CIC in cancer, a complete comprehension of CIC-rearranged activity is still required before providing new potential avenues for therapy...
November 2, 2022: Cancers
https://read.qxmd.com/read/36346232/respiratory-syncytial-virus-two-step-infection-screen-reveals-inhibitors-of-early-and-late-life-cycle-stages
#37
JOURNAL ARTICLE
Svenja M Sake, Christina Kosch, Sebastian Blockus, Sibylle Haid, Antonia P Gunesch, Xiaoyu Zhang, Martina Friesland, Sofie B Trummer, Christina Grethe, Anne Kühnel, Jessica Rückert, W Paul Duprex, Jiabin Huang, Marie-Anne Rameix-Welti, Martin Empting, Nicole Fischer, Anna K H Hirsch, Thomas F Schulz, Thomas Pietschmann
Human respiratory syncytial virus (hRSV) infection is a leading cause of severe respiratory tract infections. Effective, directly acting antivirals against hRSV are not available. We aimed to discover new and chemically diverse candidates to enrich the hRSV drug development pipeline. We used a two-step screen that interrogates compound efficacy after primary infection and a consecutive virus passaging. We resynthesized selected hit molecules and profiled their activities with hRSV lentiviral pseudotype cell entry, replicon, and time-of-addition assays...
November 8, 2022: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/36339907/superficial-solitary-fibrous-tumor-masquerading-as-a-dermoid-cyst-a-case-report
#38
Michael G Foss, Charles Dunn, Etan Marks, Rajiv Nathoo
Background: Solitary fibrous tumors (SFTs) are relatively rare spindle cell neoplasms uncommonly seen in dermatology practice. Initially discovered as a pleural tumor, SFTs have also been found in extra-pleural sites including the skin and soft tissues. When arising within the dermis or subcutis they are termed superficial SFTs, where they often present as solitary, unilateral, slow growing superficial masses. Histologically, they are composed of spindle cells arranged in a "patternless" pattern with hemangiopericytoma-like vessels dispersed throughout...
2022: AME Case Reports
https://read.qxmd.com/read/36301997/venus-an-efficient-virus-infection-detection-and-fusion-site-discovery-method-using-single-cell-and-bulk-rna-seq-data
#39
JOURNAL ARTICLE
Che Yu Lee, Yuhang Chen, Ziheng Duan, Min Xu, Matthew Girgenti, Ke Xu, Mark Gerstein, Jing Zhang
Early and accurate detection of viruses in clinical and environmental samples is essential for effective public healthcare, treatment, and therapeutics. While PCR detects potential pathogens with high sensitivity, it is difficult to scale and requires knowledge of the exact sequence of the pathogen. With the advent of next-gen single-cell sequencing, it is now possible to scrutinize viral transcriptomics at the finest possible resolution-cells. This newfound ability to investigate individual cells opens new avenues to understand viral pathophysiology with unprecedented resolution...
October 27, 2022: PLoS Computational Biology
https://read.qxmd.com/read/36271030/a-novel-network-pharmacology-approach-for-leukaemia-differentiation-therapy-using-mogrify-%C3%A2
#40
JOURNAL ARTICLE
Lin Ming Lee, Eleni G Christodoulou, Pavithra Shyamsunder, Bei Jun Chen, Kian Leong Lee, Tsz Kan Fung, Chi Wai Eric So, Gee Chuan Wong, Enrico Petretto, Owen J L Rackham, S Tiong Ong
Acute myeloid leukaemia (AML) is a rapidly fatal blood cancer that is characterised by the accumulation of immature myeloid cells in the blood and bone marrow as a result of blocked differentiation. Methods which identify master transcriptional regulators of AML subtype-specific leukaemia cell states and their combinations could be critical for discovering novel differentiation-inducing therapies. In this proof-of-concept study, we demonstrate a novel utility of the Mogrify® algorithm in identifying combinations of transcription factors (TFs) and drugs, which recapitulate granulocytic differentiation of the NB4 acute promyelocytic leukaemia (APL) cell line, using two different approaches...
October 21, 2022: Oncogene
keyword
keyword
64516
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.